Literature DB >> 24728816

Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.

D Vodovar1, G Marcadé, H Rousseau, L Raskine, E Vicaut, N Deye, F J Baud, B Mégarbane.   

Abstract

We investigated the predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-PE) causing infections among intensive care unit patients with prior documented ESBL-PE colonization. Using multivariate analysis, referral from medical ward, nursing home or rehabilitation center [Odds ratio (OR), 2.5; 95 % confidence interval (CI), [1.3-5.0]; p = 0.007], previous fluoroquinolone treatment (OR, 3.4; CI, [1.1-10.5]; p = 0.003), extracorporeal membrane oxygenation (OR, 4.6; CI, [1.3-15.9]; p = 0.02), and absence of prior positive ESBL-PE rectal swab culture (OR, 5.0; CI, [1.6-10.0]; p = 0.0009) were risk factors for ESBL-PE infection. Easily identifiable factors may help with targeting carbapenem prescriptions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24728816     DOI: 10.1007/s15010-014-0619-z

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

1.  Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum beta-lactamases.

Authors:  Hélène Réglier-Poupet; Thierry Naas; Amélie Carrer; Anne Cady; Jean-Marie Adam; Nicolas Fortineau; Claire Poyart; Patrice Nordmann
Journal:  J Med Microbiol       Date:  2008-03       Impact factor: 2.472

2.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

3.  Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis.

Authors:  Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Antimicrob Chemother       Date:  2007-09-11       Impact factor: 5.790

4.  β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.

Authors:  Jesús Rodríguez-Baño; María Dolores Navarro; Pilar Retamar; Encarnación Picón; Álvaro Pascual
Journal:  Clin Infect Dis       Date:  2011-11-04       Impact factor: 9.079

5.  Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

Authors:  D L Paterson; L Mulazimoglu; J M Casellas; W C Ko; H Goossens; A Von Gottberg; S Mohapatra; G M Trenholme; K P Klugman; J G McCormack; V L Yu
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

Review 6.  Effect of antimicrobial agents on the ecological balance of human microflora.

Authors:  A Sullivan; C Edlund; C E Nord
Journal:  Lancet Infect Dis       Date:  2001-09       Impact factor: 25.071

Review 7.  Extended-spectrum beta-lactamase-producing organisms.

Authors:  M E Falagas; D E Karageorgopoulos
Journal:  J Hosp Infect       Date:  2009-07-10       Impact factor: 3.926

8.  Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.

Authors:  Laurence Armand-Lefèvre; Cécile Angebault; François Barbier; Emilie Hamelet; Gilles Defrance; Etienne Ruppé; Régis Bronchard; Raphaël Lepeule; Jean-Christophe Lucet; Assiya El Mniai; Michel Wolff; Philippe Montravers; Patrick Plésiat; Antoine Andremont
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

9.  Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?

Authors:  T Goulenok; A Ferroni; E Bille; H Lécuyer; O Join-Lambert; P Descamps; X Nassif; J-R Zahar
Journal:  J Hosp Infect       Date:  2013-07-08       Impact factor: 3.926

10.  National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience.

Authors:  Anne Carbonne; Isabelle Arnaud; Sylvie Maugat; Nicole Marty; Catherine Dumartin; Xavier Bertrand; Odile Bajolet; Anne Savey; Thierry Fosse; Mathieu Eveillard; Hélène Sénéchal; Bruno Coignard; Pascal Astagneau; Vincent Jarlier
Journal:  J Antimicrob Chemother       Date:  2012-11-29       Impact factor: 5.790

View more
  10 in total

1.  Subsequent infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization.

Authors:  Anna Lindblom; Nahid Karami; Tim Magnusson; Christina Åhrén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-23       Impact factor: 3.267

2.  Extended-spectrum beta-lactamase producing Enterobacteriaceae in the intensive care unit: persistent issues to understand the transition from colonization to infection.

Authors:  D Vodovar; B Mégarbane
Journal:  Infection       Date:  2014-08-29       Impact factor: 3.553

3.  Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.

Authors:  L A Denkel; P Gastmeier; R Leistner
Journal:  Infection       Date:  2014-08-27       Impact factor: 3.553

4.  Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae.

Authors:  François Barbier; Sébastien Bailly; Carole Schwebel; Laurent Papazian; Élie Azoulay; Hatem Kallel; Shidasp Siami; Laurent Argaud; Guillaume Marcotte; Benoît Misset; Jean Reignier; Michaël Darmon; Jean-Ralph Zahar; Dany Goldgran-Toledano; Étienne de Montmollin; Bertrand Souweine; Bruno Mourvillier; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2018-04-16       Impact factor: 17.440

5.  Frequency, associated factors and outcome of multi-drug-resistant intensive care unit-acquired pneumonia among patients colonized with extended-spectrum β-lactamase-producing Enterobacteriaceae.

Authors:  Keyvan Razazi; Armand Mekontso Dessap; Guillaume Carteaux; Chloé Jansen; Jean-Winoc Decousser; Nicolas de Prost; Christian Brun-Buisson
Journal:  Ann Intensive Care       Date:  2017-06-12       Impact factor: 6.925

6.  Derivation and validation of a simple score to predict the presence of bacteria requiring carbapenem treatment in ICU-acquired bloodstream infection and pneumonia: CarbaSCORE.

Authors:  Laura Teysseyre; Cyril Ferdynus; Guillaume Miltgen; Thomas Lair; Thomas Aujoulat; Nathalie Lugagne; Nicolas Allou; Jérôme Allyn
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-20       Impact factor: 4.887

7.  Prevalence and patient related factors associated with Extended-Spectrum Beta-Lactamase producing Escherichia coli and Klebsiella pneumoniae carriage and infection among pediatric patients in Tanzania.

Authors:  Nuru Letara; James Samwel Ngocho; Nahid Karami; Sia E Msuya; Balthazar Nyombi; Nancy A Kassam; Susann Skovbjerg; Christina Åhren; Rune Philemon; Blandina T Mmbaga
Journal:  Sci Rep       Date:  2021-11-23       Impact factor: 4.379

8.  From Pathophysiological Hypotheses to Case-Control Study Design: Resistance from Antibiotic Exposure in Community-Onset Infections.

Authors:  Salam Abbara; Didier Guillemot; Christian Brun-Buisson; Laurence Watier
Journal:  Antibiotics (Basel)       Date:  2022-02-04

9.  Diagnostic Accuracy of Infection Markers to Diagnose Infections in Neonates and Children Receiving Extracorporeal Membrane Oxygenation.

Authors:  Irene Doo; Lukas P Staub; Adrian Mattke; Emma Haisz; Anna Lene Seidler; Nelson Alphonso; Luregn J Schlapbach
Journal:  Front Pediatr       Date:  2022-01-26       Impact factor: 3.418

Review 10.  Empiric Treatment in HAP/VAP: "Don't You Want to Take a Leap of Faith?"

Authors:  Khalil Chaïbi; Gauthier Péan de Ponfilly; Laurent Dortet; Jean-Ralph Zahar; Benoît Pilmis
Journal:  Antibiotics (Basel)       Date:  2022-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.